Global Semen Analysis Market - 2022-2029
Market Overview
Semen Analysis Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 4.5 % during the forecast period (2022-2029).
A test called sperm analysis is performed to assess the viability, health, and quality of sperm. It is done by couples unable to conceive naturally and for medical purposes like animal breeding. The analysis is done to check basic factors such as semen volume, sperm concentration, motility, morphology, and viability based on various criteria. Since sperm count can vary daily and an average of the sperm samples might provide the most conclusive result, the tests are performed over two to three months with at least seven days between each.
Market Dynamics
Improvements in sperm test accuracy measurement technology are expected to drive market growth.
Male infertility affects up to 12% of men. Although manual testing utilizing a microscope examination and computer-assisted semen analysis are common techniques for determining sperm count and motility, these techniques have limitations because they are laboratory-based. To look at the practicality of a brand-new semen analysis tool employing a smartphone camera. For instance, Men undergoing vasectomy and vasovasostomy procedures can also be monitored at home using this smartphone-based semen tester(OVIEW-M test). More than 33 million married couples choose vasectomy over female sterilization as a method of contraception because they believe it to be safer, less expensive, and easier. By offering a quick, simple, affordable, and customized method that precisely detects sperm concentration and motility, the smartphone-based semen analyzer may increase compliance with semen analysis following vasectomy.
Similarly, the sperm of men who have undergone varicocelectomy and vasovasostomy for infertility should be assessed postoperatively. These people could also use the semen analyzer that is compatible with smartphones. Thus, from the above statements, the market is expected to drive in the forecast period.
Restraint:
Lack of public awareness, the high expense of assisted reproductive technology, Medical devices being subject to strict tax regulations, and erroneous results produced by semen instruments are some factors the market is expected to get hampered in the forecast period.
Industry Analysis
The semen analysis market provides in-depth analysis of the market based on various industry factors such as porter’s five forces, reimbursement scenario, pricing analysis, supply chain etc.
COVID-19 Impact Analysis
The COVID-19 pandemic has moderately impacted healthcare systems and the market. Numerous research has suggested that COVID-19 may impact the testicles and male genital system, disturbing gonadal functioning. The direct cytotoxic effects of SARS-CoV-2 on the target cells and the indirect damage caused by the inflammatory response to the virus may contribute to the disease's damaging consequences. Moreover, patients experienced significant delays in diagnostic procedures like laparoscopy and laparoscopic sperm retrieval, blood tests, semen analysis, and other surgical procedures. Months to more than two years of delays are experienced. By the time they could receive therapy, many patients had to repeat outdated testing, and many complained that appointments were canceled.
Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of the economic activities.
Segment Analysis
Analyzers segment is expected to hold the largest market share in semen analysis market
The analyzers segment is expected to dominate in 2021. CASA systems are automated tools that assess data from a microscopic evaluation using cameras and software to produce results for semen parameter values. CASA systems are first mostly utilized in laboratories for research. But while they supposedly lessen subjectivity and human error and standardize the semen analysis procedure, their use has expanded into therapeutic practice. Additionally, they enable the examination of more samples in less time, decreasing the total time required and boosting productivity. Therefore, CASA systems can potentially take the position of manual semen analysis in laboratories. These machines are now faster, smaller, and more accurate because of technological improvements over the past 40 years. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.
Geographical Analysis
North America region holds the largest market share in the global semen analysis market
In 2021, North America accounted for the highest revenue share. The increasing prevalence of male infertility, technological advancement in the semen analysis analyzers, product launches by the market players, high adoption of the semen analysis kits and favorable reimbursement policies in the region are some factors the market is expected to boost in the forecast period. For instance, one in every six couples attempting to get pregnant has infertility. Male factors are a main or contributing cause in at least half of all occurrences of infertility. This indicates that approximately 10% of American men trying to get pregnant are infertile. Moreover, In January 2019, Medical Electronic Systems, LLC announced the availability of the YO Home Sperm Test for PC platforms and the release of an evaluation score called the YO SCORE, which has been proven effective by Cleveland Clinic. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.
Competitive Landscape
Major key players in the semen analysis market are Hamilton Thorne, Inc., DNA Diagnostics Center, Microptic S.L., CooperSurgical, Inc., AKYmed Ltd, Medical Electronic Systems, LLC, ARQUIMEA Agrotech, Sperm Processor, MotilityCount ApS, Bioline Technologies.
Medical Electronic Systems, LLC:
Overview:
Medical Electronics Systems was founded in 1993 and is based in Israel. MES is involved in producing instruments required for semen analysis. The company provides semen analyzers for humans as well as for veterinary. In veterinary, they provide analyzers for equine, porcine, bovine, and turkey. Moreover, the company has its geographic presence in America, Asia and the Pacific, Africa, and the Middle East. The company’s subsidiary, Advanced Agricultural Technologies (A-Tech), established in 2007, provides rapid automated semen analysis and related products for the veterinary market
Product Portfolio:
QwikCheck Quality Control Beads: A three-level quality control tool for use with sperm counting machines that are both automatic and manual. By supplying a known goal value, the beads, which are exclusively intended for in-vitro use, can be used to evaluate the precision and accuracy of the laboratory's sperm counting procedures.
The global semen analysis market report would provide an access to an approx. 45+market data table, 40+figures and 160pages.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook